FRAT1 and non-small cell lung carcinoma: Other potential markers of NSCLC metastasis include six urinary exosomal-derived lncRNAs lnc-(SRY-11, lnc-FRAT1-5, and lnc-RNASE13-1), which exhibited significantly higher expression levels in NSCLC patients compared to healthy individuals.